心脏磁共振T1 mapping和特征追踪技术定量评价肥厚型心肌病患者心肌纤维化和形变

崔越, 曹玉坤, 刘佳, 等. 心脏磁共振T1 mapping和特征追踪技术定量评价肥厚型心肌病患者心肌纤维化和形变[J]. 临床心血管病杂志, 2020, 36(9): 856-862. doi: 10.13201/j.issn.1001-1439.2020.09.017
引用本文: 崔越, 曹玉坤, 刘佳, 等. 心脏磁共振T1 mapping和特征追踪技术定量评价肥厚型心肌病患者心肌纤维化和形变[J]. 临床心血管病杂志, 2020, 36(9): 856-862. doi: 10.13201/j.issn.1001-1439.2020.09.017
CUI Yue, CAO Yukun, LIU Jia, et al. Quantification of left ventricular myocardial fibrosis and deformation using cardiovascular magnetic resonance T1 mapping and feature tracking technique in hypertrophic cardiomyopathy patients[J]. J Clin Cardiol, 2020, 36(9): 856-862. doi: 10.13201/j.issn.1001-1439.2020.09.017
Citation: CUI Yue, CAO Yukun, LIU Jia, et al. Quantification of left ventricular myocardial fibrosis and deformation using cardiovascular magnetic resonance T1 mapping and feature tracking technique in hypertrophic cardiomyopathy patients[J]. J Clin Cardiol, 2020, 36(9): 856-862. doi: 10.13201/j.issn.1001-1439.2020.09.017

心脏磁共振T1 mapping和特征追踪技术定量评价肥厚型心肌病患者心肌纤维化和形变

  • 基金项目:

    湖北省分子影像重点实验室基金(No:02.03.2018-90)

详细信息
    通讯作者: 刘晓庆,E-mail:lxq_xh@163.com
  • 中图分类号: R542.2

Quantification of left ventricular myocardial fibrosis and deformation using cardiovascular magnetic resonance T1 mapping and feature tracking technique in hypertrophic cardiomyopathy patients

More Information
  • 目的:探讨心脏磁共振(CMR)T1 mapping和特征追踪(FT-CMR)技术定量肥厚型心肌病(HCM)患者心肌纤维化和心肌形变的诊断价值及其相关性。方法:本研究共纳入25例HCM患者(HCM组)和28例健康志愿者(对照组)行1.5-T心脏磁共振检查。CMR T1 mapping扫描采用改良的Look-Locker反转恢复(MOLLI)序列,扫描范围包括左室基底、中间和心尖段的T1 mapping图。按照美国心脏病协会(AHA)左室心肌分段方法将左室心肌分为16段,并测量每段心肌的初始T1值、增强后T1值和心肌细胞外容积(ECV)值。将心脏长轴二、三和四腔心和全部短轴位电影图像导入心肌应力分析软件,通过分析得到左室整体纵向(GLS)、周向(GCS)和径向(GRS)心肌收缩应力。比较HCM组和对照组的T1值、ECV值和心肌收缩应变的差异,并分析其相关性。结果:HCM组左室整体心肌平均初始T1值和ECV值均高于对照组,差异有统计学意义[初始T1值:(1 047.3±43.7) ms∶(1 013.8±26.9) ms,P=0.001;ECV值:(28.2±4.7)%∶(24.0±1.9)%,P<0.001]。HCM组左室GLS和GCS均低于对照组,差异有统计学意义[GLS:(-13.6±3.7)%∶(-16.9±1.9)%,P<0.001;GCS:(-16.3±4.8)%∶(-19.2±2.7)%,P=0.011]。多变量回归分析显示,HCM患者性别和GRS与左室心肌ECV均存在独立相关性(性别:标准化β=0.429,P=0.012;GRS:标准化β=-0.471,P=0.007)。与初始T1时间和心肌应力相比,ROC曲线分析示心肌ECV对HCM诊断价值最大(AUC=0.846,P<0.001),ECV诊断HCM的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为80.0%、85.7%、83.3%和82.8%。结论:HCM患者的心肌初始T1值和ECV增高,与心肌弥漫性纤维化有关。HCM患者与健康对照比较射血分数(EF)正常而GLS和GCS降低,提示心肌应力比EF能更早地反映心功能受损。HCM患者的心肌纤维化与性别和GRS相关。相对于初始T1时间和心肌应力,心肌ECV诊断HCM的价值较大。
  • 加载中
  • [1]

    Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies[J].Circulation,2006,113(14):1807-1816.

    [2]

    Felker GM,Thompson RE,Hare JM,et al.Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy[J].N Eng J Med,2000,342(15):1077-1084.

    [3]

    Maron BJ.Hypertrophic cardiomyopathy-A systematic review[J].J Am Med Assoc,2002,287(10):1308-1320.

    [4]

    Prinz C,van Buuren F,Faber L,et al.Myocardial fibrosis is associated with biventricular dysfunction in patients with hypertrophic cardiomyopathy[J].J Cardiovasc Ultrasound Allied Tech,2012,29(4):438-444.

    [5]

    O'Hanlon R,Grasso A,Roughton M,et al.Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy[J].JACC,2010,56(11):867-874.

    [6]

    Bruder O,Wagner A,Jensen CJ,et al.Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy[J].JACC,2010,56(11):875-887.

    [7]

    何丽,蒋谨,尚兰.心脏磁共振对肥厚型心肌病应用价值的研究[J].临床心血管病杂志,2018,34(1):86-90.

    [8]

    Caudron J,Fares J,Bauer F,et al.Evaluation of left ventricular diastolic function with cardiac MR imaging[J].Radiographics,2011,31(1):239-259.

    [9]

    Schuster A,Stahnke VC,Unterberg-Buchwald C,et al.Cardiovascular magnetic resonance feature-tracking assessment of myocardial mechanics:Intervendor agreement and considerations regarding reproducibility[J].Clin Radiol,2015,70(9):989-998.

    [10]

    Cerqueira MD,Weissman NJ,Dilsizian V,et al.Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart [J].Circulation,2002,105(4):539-542.

    [11]

    曹玉坤,崔越,曾文娟,等.1.5T磁共振定量正常人左室心肌组织特性和心肌应变的初步研究[J].临床心血管病杂志,2017,33(11):1077-1082.

    [12]

    Miller CA,Naish JH,Bishop P,et al.Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume[J].Circ-Cardiovasc Imaging,2013,6(3):373-383.

    [13]

    Iles LM,Ellims AH,Llewellyn H,et al.Histological validation of cardiacmagnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis[J].Cardiovasc Imaging,2015,16(1):14-22.

    [14]

    de Ravenstein CD,Bouzin C,Lazam S,et al.Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T[J].J Cardiovasc Magn Reson,2015,17:11-11.

    [15]

    Flett AS,Hayward MP,Ashworth MT,et al.Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis preliminary validation in humans[J].Circulation,2010,122(2):138-U72.

    [16]

    Bull S,White SK,Piechnik SK,et al.Human non-contrast T1 values and correlation with histology in diffuse fibrosis[J].Heart,2013,99(13):932-937.

    [17]

    Sibley CT,Noureldin RA,Gai N,et al.T1 Mapping in cardiomyopathy at cardiac MR:comparison with endomyocardial biopsy[J].Radiology,2012,265(3):724-732.

    [18]

    Diao KY,Yang ZG,Xu HY,et al.Histologic validation of myocardial fibrosis measured by T1 mapping:a systematic review and meta-analysis[J].J Cardiovasc Magn Reson,2016,18(1):92-92.

    [19]

    Dass S,Suttie JJ,Piechnik SK et al.Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy[J].Cardiovasc Imaging,2012,5(6):726-733.

    [20]

    Puntmann VO,Voigt T,Chen Z,et al.Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy[J].JACC-Cardiovasc Imag,2013,6(4):475-484.

    [21]

    Wu LN,Germans T,Guclu A,et al.Feature tracking compared with tissue tagging measurements of segmental strain by cardiovascular magnetic resonance[J].J Cardiovas Magn Reson,2014,16:10-11.

    [22]

    Shirani J,Pick R,Roberts WC,et al.Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death[J].JACC,2000,35(1):36-44.

    [23]

    Nucifora G,Muser D,Gianfagna P,et al.Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy,replacement fibrosis and interstitial fibrosis[J].Int J Cardiovasc Imaging,2015,31(8):1603-1610.

    [24]

    Dusenbery SM,Lunze FI,Jerosch-Herold M,et al.Left ventricular strain and myocardial fibrosis in congenital aortic stenosis[J].Am J Cardiol,2015,116(8):1257-1262.

  • 加载中
计量
  • 文章访问数:  691
  • PDF下载数:  655
  • 施引文献:  0
出版历程
收稿日期:  2019-03-27

目录